Trial intelligence / Profile preview

Outpatient Levofloxacin for Pediatric Fever and Neutropenia

NCT03768869Phase 3Withdrawn

Sponsor
University of Colorado Denver
Start
Feb 2006
Primary completion
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levofloxacin in fever, neutropenia, sponsored by University of Colorado Denver. Planned start Feb 2006; status: withdrawn.

02

Drugs

levofloxacin
03

Conditions

feverneutropenia

Beyond the preview

Go deeper on NCT03768869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03768869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call